Roswell, GA – Dynamic Technical Formulations LLC. is voluntarily recalling all lots of Tri-Ton. This product was sold in 90 count bottles as a dietary supplement and includes all lot number and expiration dates of the product. The US Food and Drug Administration (FDA) lab analysis of Tri-Ton was found to contain andarine and ostarine which are selective androgen receptor modulators (SARMs) that are considered unapproved drugs and anabolic steroid-like substances.
Use or consumption of products containing SARMs and anabolic steroid-like substances may cause acute liver injury, which is known to be a possible harmful effect of using steroid containing products. In addition, abuse of anabolic steroids may cause other serious long-term adverse health consequences in men, women, and children. These include shrinkage of the testes and male infertility, masculinization of women, breast enlargement in males, short stature in children, a higher predilection to misuse other drugs and alcohol, adverse effects on blood lipid levels, and increased risk of heart attack, stroke, and death.
This product was sold in 90 count bottles through retailers nationwide. Shipment of this product was from June 2016 to March 2017. Consumers should stop using the product immediately and throw it away in accordance with your state and local ordinances for disposal of drug products or return the unused portion of product for a refund. Dynamic Technical Formulations has not received any reports of illnesses to date.
Dynamic Technical Formulations, LLC is committed to providing accurate information about its products because of concerns for the health and safety of consumers. Dynamic Technical Formulations is working voluntarily with the FDA in the recall process. It sincerely regrets any inconvenience to customers. The company has discontinued distribution of these affected products.
Consumers with questions regarding this recall can contact Dynamic Technical Formulations by emailing customerservice@dtformulations.com or calling 800-331-6723 from 9:00am to 5:00pm EST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking these products or using this drug product.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
###
Leave a Reply